19-07-2004 Comments (0)
Abbott LaboratoriesAciphexActosAstraZenecaEisaiKyowa HakkoLansoprazoleLillyMitsubishi PharmaOlopatadineOmeprazolePatanolPioglitazonePrevacidPrevacid NapraPACPrilosecRabeprazole SodiumSolifenacin SuccinateVESIcare
Tokyo saw a modest rally in the week ended July 12. The Nikkei 225 edgedup 0.4%, recovering the 11,500…
A trial subscription will give you access to the latest news on The Pharma Letter for 7 days, in order to evaluate the paid service.